Precision fermentation: which startup is ahead?
In our alternative protein market deck, you will find everything you need to understand the market
SUMMARY
The EVERY Company is ahead in precision fermentation today, with Perfect Day close behind and no third startup yet matching their combination of repeat production, real demand and industrial readiness.
Only EVERY and Perfect Day have clearly moved beyond launches and demonstrations into repeated commercial protein production at meaningful scale. That is the dividing line in this market.
EVERY has the strongest visible commercial momentum: regular metric-ton deliveries, national US retail exposure and 2026 annual orders equal to 5.5 times its total 2025 order volume. Its expanded Huvepharma agreement also gives it more capacity without the burden of building a wholly owned factory network.
Perfect Day still has the biggest scale option. It has more funding, more years of dairy-protein production experience and a large manufacturing project in Gujarat, but that plant has to prove stable yield, purity and uptime before planned capacity becomes leadership.
The next tier is split by protein rather than controlled by one obvious number three. Remilk and Imagindairy lead in visible consumer dairy launches, Helaina leads in high-value lactoferrin, and Onego Bio is the most credible future challenger to EVERY in egg protein.
Lactoferrin may produce the best business before it produces the biggest company. Helaina can build attractive economics at much lower volumes because conventional lactoferrin is scarce and expensive, while whey, egg and casein startups must eventually compete with large commodity supply chains.
Formo's retail footprint is impressive, but it should not be confused with proof that precision-fermented casein already works at scale. Most of its current commercial volume comes from koji-based products, so the core casein test is still ahead.
Regulatory clearance is no longer enough to separate the leaders. EVERY, Perfect Day, Remilk, Onego Bio and TurtleTree have cleared major US barriers; the harder question is who converts approval into repeat batches, repeat customers and acceptable unit economics.
Funding is a weak proxy for current leadership. Perfect Day has raised almost 2.8 times as much as EVERY, yet EVERY shows the sharper public evidence of current demand, while Imagindairy and Helaina have reached meaningful milestones with far less capital.
The ranking can still move quickly. A clean Perfect Day factory ramp could put it first, while repeat orders at EVERY's expanded capacity could create a wider lead; below them, one reliable commercial plant or multi-market consumer launch would materially change the middle of the table.
This market map, featured in our alternative protein market deck, highlights top companies and startups in the alternative protein market
Which precision fermentation startups are actually in the race?
The current precision fermentation race has ten credible startups, but only EVERY and Perfect Day have clearly reached repeat commercial production at meaningful scale.
We are comparing companies that use engineered microorganisms to produce specific animal proteins for food or nutrition, including egg proteins, whey, casein and lactoferrin. We exclude biomass-fermentation companies such as Solar Foods and Air Protein, because their product is the microorganism itself. We also exclude inactive ventures and incumbent-controlled businesses such as Vivici, the Fonterra and DSM-Firmenich joint venture, although those companies can still put pressure on startups.
The field has narrowed. The Precision Fermentation Alliance once included Motif FoodWorks alongside EVERY, Perfect Day, Remilk, Imagindairy, Helaina, Onego Bio, New Culture and Change Foods. Motif later shut down, Change Foods has remained early, and TurtleTree and Standing Ovation have moved closer to real launches through regulatory progress, financing and manufacturing partnerships.
Funding figures are approximate because private-company databases mix equity, debt, grants and undisclosed extensions.
| Startup | Main protein or product | Commercial position today | Approximate cumulative funding |
|---|---|---|---|
| Perfect Day | Dairy proteins, led by beta-lactoglobulin | Commercial supply, with major new capacity still ramping | More than $825 million |
| The EVERY Company | Ovalbumin and other egg proteins | Repeat industrial production and products in national US retail | About $294 million |
| Remilk | Dairy proteins, initially beta-lactoglobulin | Consumer milk launched through an established dairy company | About $171 million |
| Formo | Casein and fermentation-based cheese products | Retail products exist, while precision-fermented casein remains earlier | About €135 million including debt |
| Helaina | Human lactoferrin and related bioactive proteins | Commercial ingredient used by nutrition brands | About $83 million |
| Onego Bio | Ovalbumin sold as Bioalbumen | US safety milestone reached, with commercial production still being built | About $71 million |
| Standing Ovation | Casein | Pre-commercial scale-up with major dairy investors | Roughly $50 million |
| TurtleTree | Lactoferrin sold as LF+ | Regulatory progress and manufacturing partnerships established | About $42 million |
| New Culture | Casein for mozzarella | Advanced demonstrations and customer interest, but limited broad sales | About $37 million |
| Imagindairy | Dairy proteins including beta-lactoglobulin | Consumer launch through Strauss and access to large fermentation equipment | About $30 million |
Is there a clear precision fermentation leader today?
EVERY is currently ahead overall, with Perfect Day close enough that the lead could still change quickly.
EVERY is already producing, selling and adding capacity. The company says it is supplying metric tons regularly, its proteins appear in products sold through Walmart, Target and Amazon, and its latest Huvepharma agreement increased available production fourfold.
Perfect Day remains the only challenger with a realistic path to taking first place soon. It has raised more than $825 million, has several years of commercial dairy-protein experience and says current output is effectively committed. Its Gujarat operation could move it into a different scale bracket once the facility runs reliably.
Below those two, the market splits by protein. Remilk and Imagindairy are strongest in consumer dairy launches. Helaina leads the higher-value lactoferrin niche. Formo has built the broadest European retail presence among this group, although its precision-fermented casein still accounts for little of that activity. Onego is the most direct threat to EVERY in egg proteins, but it still has to turn regulatory readiness into regular supply.
If you want more recent data on this point, please see our latest alternative protein market report.
As this chart shows, and as featured in our alternative protein market deck, search interest in pea protein has been growing steadily
Which precision fermentation startup has created the strongest real demand?
EVERY currently has the strongest visible demand because retailers, food manufacturers, food-service buyers and online customers are buying at the same time.
In the first four months of 2026, EVERY said it booked annual orders equal to 5.5 times its entire 2025 order volume. Orders arrive before recognized revenue, but a jump of that size is difficult to dismiss when production is already running and capacity is expanding.
Its presence in Walmart, Target and Amazon also shows that the protein can move through national retail systems with demanding supply, traceability and quality requirements. EVERY sells through food service, direct-to-consumer products and manufacturing partnerships as well, reducing its dependence on one launch or customer.
Perfect Day may already sell more protein in absolute volume, but outsiders cannot see enough detail to prove it. Management says existing plants are sold out and early output from its new facility has been allocated. That points to real industrial demand, although customer volumes, contract lengths and minimum-purchase terms remain private.
Remilk and Imagindairy have crossed an important line by putting precision-fermented dairy proteins into consumer products through Gad Dairies and Strauss. Danone's investment in Imagindairy adds another credible route into global dairy markets. We still lack repeat-purchase data and disclosed production volumes, so both remain behind the top two.
Helaina deserves a different reading. Lactoferrin sells at a much higher value per kilogram than whey or egg protein, meaning smaller volumes can still support a serious business. Its use in branded nutrition products gives Helaina the strongest demand case among specialist-protein companies.
Which precision fermentation startup is growing fastest now?
EVERY is growing fastest based on the commercial numbers companies have shared, and the gap is currently wide.
Its 5.5-times order comparison shows a sharp break from normal year-to-year growth. The company has also added national retail exposure, hired its first chief revenue officer and expanded its Huvepharma production agreement.
The latest manufacturing agreement increased EVERY's available capacity fourfold. The extra production followed the order increase, which makes the growth claim more convincing than a demand announcement on its own.
Perfect Day has the largest possible step-up, but much of that growth still depends on its new-facility ramp. Standing Ovation has accelerated in financing after assembling a €30 million package involving public money and investors linked to Danone and Bel. Remilk has advanced through a real consumer launch, while TurtleTree has paired regulatory progress with a Novonesis manufacturing partnership.
This chart, featured in our alternative protein market deck, shows annual venture capital investment in alternative protein startups
Which precision fermentation startup has the most mature product?
EVERY and Perfect Day have the most mature precision fermentation products, with EVERY ahead in visible retail use and Perfect Day ahead in years of dairy-protein production experience.
A mature product in this market must survive reliable protein expression, industrial purification, regulatory review, customer formulation and repeat manufacturing. EVERY and Perfect Day have completed that chain in commercial settings.
EVERY's OvoPro is being produced regularly and used in products that consumers can buy through mainstream channels. The powder also has an 18-month shelf life, giving food manufacturers a practical advantage over refrigerated liquid eggs. Perfect Day has supplied beta-lactoglobulin for several years across ice cream, cream cheese, baked products and nutrition applications.
Remilk and Imagindairy have products mature enough for consumer dairy launches, but their commercial histories are shorter. Helaina has reached a mature position inside the narrower lactoferrin market. Formo has mature retail operations, yet its current products mainly prove that Formo can sell fermented food rather than scaled precision-fermented casein.
Onego, TurtleTree, New Culture and Standing Ovation have each removed important technical or regulatory risks. Their next test is repeated production for paying customers.
| Startup | Product maturity today | Best proof | Main gap |
|---|---|---|---|
| EVERY | Full commercial production | Regular industrial output and broad US retail availability | Profitability and repeat demand at the new capacity level |
| Perfect Day | Full commercial production | Multi-year dairy-protein supply and committed output | Reliable ramp of major new capacity |
| Remilk | Early consumer commercialization | Branded milk launched with Gad Dairies | Public sales and repeat-volume data |
| Imagindairy | Early consumer commercialization | Strauss launch and large-equipment access | Wider geography and sustained volume |
| Helaina | Commercial specialist ingredient | Effera used in nutrition products | More disclosure on recurring sales |
| Formo | Commercial food company, earlier core precision-fermented protein | More than 2,000 retail locations for current products | Commercial proof for precision-fermented casein |
| Onego Bio | Regulatory-ready, pre-scale | FDA no-questions letter for Bioalbumen | Operating plant and regular deliveries |
| TurtleTree | Regulatory-ready specialist | FDA no-questions letter and Novonesis partnership | Repeated commercial sales |
| New Culture | Advanced pre-commercial | Strong mozzarella demonstrations and restaurant interest | Broad paid launch |
| Standing Ovation | Scale-up stage | Fresh financing and strategic dairy investors | Commercial product availability |
Which precision fermentation startup can actually manufacture at scale?
EVERY is the only precision fermentation startup with clearly demonstrated scale today, while Perfect Day has the strongest chance of overtaking it.
EVERY chose to work inside Huvepharma's existing industrial network instead of financing a fully owned factory system. Huvepharma's Biovet operations have more than nine million litres of installed fermentation infrastructure, although only an undisclosed share is assigned to EVERY. The important point is that Huvepharma increased EVERY's allocation after the process had already reached steady operation.
EVERY says it is now delivering metric tons regularly. That connects manufacturing scale to recurring customer supply rather than a demonstration batch.
Perfect Day has taken a heavier route through its Gujarat project with Zydus Lifesciences. The 27-acre operation could eventually support much larger dairy-protein volumes, and early output has reportedly been allocated. The plant still has to reach stable yield, purity and uptime before its full scale counts.
Imagindairy has made one of the smartest lower-capital moves by gaining access to production lines with 100,000-litre fermentation equipment and downstream processing. Helaina has also reached meaningful scale for lactoferrin, where commercial success requires far fewer tons than whey or egg protein.
Formo reports triple-digit tons of monthly production, but those figures mainly relate to its koji-based products rather than precision-fermented casein.
This chart, featured in our alternative protein market deck, looks at Impossible Foods’ strategy in alternative protein
Which precision fermentation startup has the best-performing protein?
EVERY currently has the best public proof that its protein works in everyday food manufacturing, although the category still lacks a fair cross-company test.
OvoPro is designed to replace egg-white functions such as binding, gelling, foaming and whipping. EVERY says food manufacturers can use it in baked goods, pasta, prepared foods and protein bars, often with less dry powder than the weight of liquid egg being replaced because water is added separately. That can lower storage, refrigeration and spoilage costs.
Perfect Day's beta-lactoglobulin serves a different need. It is useful for high-protein drinks, powders and nutrition products because dairy proteins offer strong nutritional quality and familiar functionality. The company's recurring supply suggests that customers can formulate with it successfully, but we still lack independent comparisons against Remilk or Imagindairy on solubility, taste and processing stability.
Casein may produce the most obvious consumer difference because it controls cheese stretch, melt and structure. New Culture says its mozzarella can achieve the required performance with roughly half the casein found in conventional mozzarella. Formo and Standing Ovation are pursuing the same opportunity, but none has published broad independent results from repeated industrial cheese production.
Helaina and TurtleTree compete on purity, bioactivity and formulation stability, which are the tests that matter for lactoferrin.
If you want more recent data on this point, please see our latest alternative protein market report.
Which precision fermentation startup is closest to making the economics work?
EVERY currently offers the strongest practical value for mainstream food makers, while Helaina may reach attractive margins sooner.
The Good Food Institute's review of published techno-economic studies found estimated precision-fermentation protein costs ranging from roughly $11 to thousands of dollars per kilogram. The result changes dramatically with yield, purification losses, facility utilization and the type of protein being produced.
EVERY can offer savings beyond the ingredient price. A shelf-stable powder can reduce refrigeration, spoilage and inventory problems, and food makers may need less dry material than the liquid egg weight being removed. The recent order growth suggests that at least some customers already find the full package workable, although EVERY keeps gross margins private.
Perfect Day has a clear chance to lower unit costs through larger dairy-protein production. That depends on the new facility running at high yield and staying well utilized.
Helaina and TurtleTree have chosen a more forgiving market. Lactoferrin is scarce and expensive in conventional supply, so they can build a viable business without matching commodity whey prices. Helaina may therefore reach healthy margins sooner, even if EVERY and Perfect Day eventually create much larger companies.
This chart, featured in our alternative protein market deck, shows annual funding in alternative protein startups
Which precision fermentation startups have cleared the hardest regulatory barriers?
Perfect Day, EVERY, Remilk and Onego have cleared the toughest US regulatory hurdle, and EVERY has made the best commercial use of it.
Perfect Day was among the first precision-fermented dairy-protein companies to receive an FDA no-questions response through the GRAS process. EVERY later secured no-questions letters for its egg proteins. Remilk completed the pathway for beta-lactoglobulin, and Onego obtained the same type of response for Bioalbumen. TurtleTree has also reached this milestone for LF+.
These reviews cover the production organism, manufacturing method, composition, possible impurities and intended use. Reaching this point removes a major technical and legal risk.
Several companies now have clearance, so commercial follow-through separates the leaders. EVERY has moved furthest by turning regulatory progress into national availability. Onego and TurtleTree still need regular production and repeat customers.
US clearance also leaves other markets to conquer. European novel-food approvals can take longer, and labeling rules vary by country.
Which precision fermentation startup has the strongest moat?
EVERY has the strongest visible patent position, while Perfect Day has the deepest accumulated manufacturing know-how.
EVERY holds US and European intellectual-property protection around recombinant ovalbumin production. Combined with an established process at Huvepharma, that creates a real barrier: a rival must produce the same protein, avoid patent problems and transfer the process into large vessels without losing yield or quality.
Onego directly challenges that advantage. The two companies target many of the same egg-protein applications, and Onego has contested parts of EVERY's patent position. The outcome could affect customer negotiations and investor confidence. Large food manufacturers also prefer more than one supplier, giving the market a reason to support a credible second source.
Perfect Day's protection is spread across strains, process settings, purification, formulation work, regulatory files and years of factory experience. That operational knowledge can be harder to copy than a single patent.
Helaina and TurtleTree benefit from producing complex, high-value proteins that demand strong purity and validation. New Culture, Formo and Standing Ovation will build defensibility mainly through casein yield, cheese performance and cost.
The biggest long-term threat comes from incumbent-backed companies. Vivici already has access to dairy customers, fermentation experience and regulatory teams through Fonterra and DSM-Firmenich.
If you want more recent data on this point, please see our latest alternative protein market report.
This chart, featured in our alternative protein market deck, compares the main business model options for alternative protein brands
Does Perfect Day's huge funding lead still matter?
Perfect Day's funding lead still matters, but it also raises the bar the company must clear.
Perfect Day has raised more than $825 million, almost 2.8 times EVERY's total. That capital funded dairy-protein development, manufacturing, consumer brands, biological-production services and a large new industrial project.
The commercial lead is much smaller than the funding gap. EVERY has reached national retail, repeat industrial supply and rapid order growth with roughly 36% of Perfect Day's capital. Imagindairy has secured a Strauss launch, Danone backing and access to 100,000-litre equipment with only a small fraction of that amount. Helaina has commercialized a premium protein with around one-tenth as much funding.
Imagindairy appears especially capital-efficient at the development stage. EVERY has the best visible efficiency among companies already selling at meaningful scale. Perfect Day may have more private revenue than outsiders can see, but the new facility now has to deliver.
Are lactoferrin startups building a better business than whey and egg companies?
Helaina may be building the easier and more profitable precision fermentation business, even if it never becomes the largest company in the sector.
Conventional lactoferrin is scarce because milk contains it at low concentrations and extracting it requires substantial processing. Customers buy it for nutritional and biological properties, so the price per kilogram sits far above commodity whey or egg protein.
That gives Helaina room to make money at lower volumes. Its Effera ingredient has reached commercial wellness and nutrition products, and the company says it has achieved metric-ton manufacturing. Those volumes would look small in whey but can be meaningful in lactoferrin.
TurtleTree follows the same logic with LF+. Its FDA progress and Novonesis partnership reduce two major risks, although Helaina remains ahead in visible finished-product use.
The downside is a smaller market. Egg, whey and casein appear across enormous food categories, while lactoferrin is concentrated in infant nutrition, healthy aging, sports nutrition and wellness.
This chart, featured in our alternative protein market deck, shows revenue breakdown by customer segment in the alternative protein market
Is Formo really ahead in precision fermentation cheese?
Formo currently leads precision fermentation cheese startups in retail execution, but scaled precision-fermented casein remains unproven.
Formo has put products into more than 2,000 stores across Germany and Austria and reports triple-digit tons of monthly production. That gives the company real experience in formulation, manufacturing, retail sales and consumer feedback.
Most of Formo's current range uses koji-based microfermentation and other ingredients. Those sales show that Formo can build a food brand and operate a supply chain, while cheap, repeat production of recombinant casein at the same scale has yet to appear.
Formo's approach may still prove smart. By entering retail early, the company can build relationships and learn what consumers buy while its casein technology matures. The next test is launching products whose key functionality comes from precision-fermented casein and showing that customers reorder them.
If you want more recent data on this point, please see our latest alternative protein market report.
Can Onego Bio catch EVERY in animal-free egg protein?
Onego can become EVERY's closest egg-protein rival, but today it remains one full commercial stage behind.
Onego's Bioalbumen uses Trichoderma reesei, a fungal production system with a long industrial history. The company has raised about $71 million, received an FDA no-questions letter and selected Jefferson County, Wisconsin, for a large US manufacturing site.
EVERY already has what Onego is still assembling: an operating production relationship, regular customer deliveries and national distribution. The planned site starts closing that gap only when it produces repeat batches at reliable cost and quality.
The patent dispute could change the race. If EVERY keeps broad protection, Onego may face a weaker negotiating position with customers and partners. If Onego succeeds in narrowing those claims, food manufacturers will gain a credible second supplier.
On a simple commercial-readiness index, we would place EVERY at 100 and Onego around 35 today.
This chart, featured in our alternative protein market deck, shows how plant-based meat product technology has evolved over time
Can we trust the numbers precision fermentation startups publish?
We can trust who is broadly ahead in precision fermentation, but many of the exact numbers remain shakier than they appear.
Regulatory records, announced funding rounds, retailer listings and the existence of operating facilities are usually verifiable. Revenue, yields, margins, order quality and capacity utilization are mostly private. A company can honestly report a large order increase without disclosing its value, cancellation terms or customer concentration.
EVERY's retail presence can be checked, and its FDA records are public. Its order-growth and production figures come from the company and Huvepharma, without audited accounts. Perfect Day's financing and new-plant construction are visible, while its sold-out-capacity claim comes from management. Helaina's production figures and New Culture's restaurant demand are also company-reported.
Funding totals create another problem. Some databases include venture debt and grants; others count only equity. Extensions and convertible instruments can also be recorded differently.
Technical claims are the hardest to compare. No public dataset tests EVERY, Onego, Perfect Day, Remilk, Imagindairy and New Culture under the same manufacturing and formulation conditions.
Our ranking gives the greatest weight to products people can buy, repeat industrial production, regulatory records, manufacturing expansion and credible customer relationships.
What could change the precision fermentation ranking?
Perfect Day can retake first place if its new dairy-protein capacity runs well, while EVERY can pull away if recent orders turn into repeat revenue and stable larger-scale production.
Perfect Day's Gujarat project has to reach target yield, purity and uptime, fulfill allocated orders and show that the larger plant lowers unit costs. A successful ramp would probably move Perfect Day into first place.
EVERY's next test is retention. The recent order surge will look far stronger if the same customers reorder, expand into more products and keep buying after any temporary pressure in the egg market fades. The company also has to maintain quality as production rises.
Remilk and Imagindairy can move upward by turning one consumer launch into several products and more countries. Helaina can climb by showing recurring ingredient revenue and broader customer use. Onego can jump once its Wisconsin facility produces reliably. New Culture and Standing Ovation can move quickly if either proves low-cost casein and converts partner interest into repeated paid demand.
Incumbent-backed suppliers may also reshape the field. A company such as Vivici can ignore the startup funding race and compete through an established dairy sales network.
In our alternative protein market deck, we identify pain points entrepreneurs should prioritize
Which precision fermentation startups are actually ahead?
EVERY is the precision fermentation startup ahead overall today, with Perfect Day close behind and no third company yet operating at the same combined level.
EVERY wins because it has the best mix of current commercial demand, operating production, visible distribution and growth. Perfect Day ranks second because its financing, experience and industrial assets remain unmatched, but it still has to turn those advantages into a clearly larger commercial position.
Remilk ranks third after converting precision-fermented dairy protein into a real consumer milk through an established dairy group. Helaina ranks fourth because it has built the strongest specialist business in a high-value protein. Imagindairy ranks fifth on capital efficiency, manufacturing access and partnerships with Strauss and Danone.
Formo, Onego and New Culture make up the next group for different reasons. Formo has the strongest retail organization, Onego has the clearest route to challenging EVERY in egg protein, and New Culture has one of the most compelling cheese applications. None has yet shown the full combination of repeated industrial output and broad paid adoption.
TurtleTree and Standing Ovation complete the top ten. Both have removed important risks through regulatory progress, partnerships or financing, but they still need regular customer deliveries.
| Rank | Startup | Why it ranks here |
|---|---|---|
| 1 | The EVERY Company | Strongest mix of repeat production, visible demand, national distribution and current growth |
| 2 | Perfect Day | Deepest financing and dairy experience, with the clearest route to much larger scale |
| 3 | Remilk | Strongest visible consumer dairy launch through an established dairy partner |
| 4 | Helaina | Most convincing high-value specialist business and an easier path to strong margins |
| 5 | Imagindairy | Exceptional capital efficiency, major dairy partners and access to large equipment |
| 6 | Formo | Real retail and manufacturing execution, but limited proof from its core precision-fermented casein |
| 7 | Onego Bio | Strong regulatory and manufacturing plan, but still behind EVERY in operating supply |
| 8 | New Culture | Strong mozzarella performance and customer interest, with broad paid adoption still pending |
| 9 | TurtleTree | Credible lactoferrin progress through regulation and manufacturing partnerships |
| 10 | Standing Ovation | Strong new financing and strategic dairy investors, with commercialization still ahead |
If you want more recent data on this point, please see our latest alternative protein market report.
OUR METHODOLOGY
This analysis asks which precision fermentation startup is ahead based on commercial execution, not reputation or headline funding. We compare visible demand, current growth, product maturity, manufacturing scale, protein performance, economic potential, regulatory progress, defensibility and capital efficiency.
We prioritized recent, observable evidence: repeat production, products reaching customers, retailer availability, regulatory records, operating manufacturing relationships, disclosed orders and concrete commercial launches. Planned factories, demonstration batches and broad claims of future capacity received less weight until they produced regular customer supply.
Each protein was judged in its own market context. Lactoferrin can support a serious business at much lower volumes than whey, egg protein or casein, so we did not apply one mechanical tonnage threshold to every company.
Funding totals are approximate. Private-company databases do not consistently separate equity, debt, grants, extensions and convertible instruments, so the figures are used as directional context rather than audited totals.
Regulatory records were treated as strong evidence that a company had cleared a major technical and legal barrier, but not as proof of commercial leadership. The ranking gives more weight to what happened after clearance: repeat batches, paid demand, national distribution and manufacturing expansion.
Company disclosures were used where private operating data were unavailable, especially for order growth, production volumes, capacity allocation and customer demand. Those claims were checked against harder evidence such as FDA records, retailer listings, named partners, facility announcements and finished-product launches wherever possible.
The final ranking aggregates the dimension-level conclusions rather than relying on one score. A company did not need to lead every category, but the top positions required the strongest combined evidence of present execution and a credible ability to sustain or expand it.
Key sources include: the FDA record for EVERY's precision-fermented egg-white protein, the FDA record for Perfect Day's beta-lactoglobulin, the FDA record for Remilk, the FDA record for Onego Bio's Bioalbumen, Onego Bio's regulatory update, Onego Bio's Wisconsin manufacturing-site announcement, TurtleTree's FDA milestone for LF+, Perfect Day's India manufacturing update, Perfect Day's consumer-brand and product disclosures, Imagindairy's manufacturing, regulatory and investment updates, New Culture's product and commercial milestones, New Culture's mozzarella performance disclosure, and New Culture's early-demand announcement.
This chart, featured in our alternative protein market deck, shows revenue split by region across Europe, Asia, North America, Africa, and South America in the alternative protein market
Related blog posts
- Biofoundries: which startup is ahead?
